These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Regulation of foamy virus gene expression. Rethwilm A Curr Top Microbiol Immunol; 1995; 193():1-24. PubMed ID: 7648870 [No Abstract] [Full Text] [Related]
6. Functional analysis of human foamy virus accessory reading frames. Baunach G; Maurer B; Hahn H; Kranz M; Rethwilm A J Virol; 1993 Sep; 67(9):5411-8. PubMed ID: 8394455 [TBL] [Abstract][Full Text] [Related]
7. Stable inhibition of hepatitis B virus expression and replication in HepG2.2.15 cells by RNA interference based on retrovirus delivery. Jia F; Zhang YZ; Liu CM J Biotechnol; 2007 Jan; 128(1):32-40. PubMed ID: 17049658 [TBL] [Abstract][Full Text] [Related]
8. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication. Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180 [TBL] [Abstract][Full Text] [Related]
9. Development of foamy virus vectors. Vassilopoulos G; Josephson NC; Trobridge G Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184 [No Abstract] [Full Text] [Related]
10. The replication strategy of foamy viruses. Rethwilm A Curr Top Microbiol Immunol; 2003; 277():1-26. PubMed ID: 12908766 [TBL] [Abstract][Full Text] [Related]
11. Complex effects of foamy virus central purine-rich regions on viral replication. Peters K; Barg N; Gärtner K; Rethwilm A Virology; 2008 Mar; 373(1):51-60. PubMed ID: 18078974 [TBL] [Abstract][Full Text] [Related]
12. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors. Sun Y; Li Z; Li L; Li J; Liu X; Li W Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648 [TBL] [Abstract][Full Text] [Related]
14. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070 [TBL] [Abstract][Full Text] [Related]
15. Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus. Müller S; Günther S Antimicrob Agents Chemother; 2007 Jun; 51(6):2215-8. PubMed ID: 17371814 [TBL] [Abstract][Full Text] [Related]
16. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Jopling CL; Yi M; Lancaster AM; Lemon SM; Sarnow P Science; 2005 Sep; 309(5740):1577-81. PubMed ID: 16141076 [TBL] [Abstract][Full Text] [Related]
17. Engineered virus-encoded pre-microRNA (pre-miRNA) induces sequence-specific antiviral response in addition to nonspecific immunity in a fish cell line: convergence of RNAi-related pathways and IFN-related pathways in antiviral response. Dang LT; Kondo H; Aoki T; Hirono I Antiviral Res; 2008 Dec; 80(3):316-23. PubMed ID: 18687362 [TBL] [Abstract][Full Text] [Related]
19. RNA interference and HIV-1 infection. Kanzaki LI; Ornelas SS; Argañaraz ER Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099 [TBL] [Abstract][Full Text] [Related]
20. Derivation and functional characterization of a consensus DNA binding sequence for the tas transcriptional activator of simian foamy virus type 1. Kang Y; Cullen BR J Virol; 1998 Jul; 72(7):5502-9. PubMed ID: 9621006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]